BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19892713)

  • 41. Comparison of echocardiography and device based algorithm for atrio-ventricular delay optimization in heart block patients.
    Vijayvergiya R; Gupta A
    World J Cardiol; 2015 Nov; 7(11):801-7. PubMed ID: 26635928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in atrioventricular and interventricular optimization of cardiac resynchronization therapy - what's the gold standard?
    Rowe MK; Kaye GC
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):183-196. PubMed ID: 29338475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement precision in the optimization of cardiac resynchronization therapy.
    Turcott RG; Witteles RM; Wang PJ; Vagelos RH; Fowler MB; Ashley EA
    Circ Heart Fail; 2010 May; 3(3):395-404. PubMed ID: 20176716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimization of AV and VV delays in the real-world CRT patient population: an international survey on current clinical practice.
    Gras D; Gupta MS; Boulogne E; Guzzo L; Abraham WT
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S236-9. PubMed ID: 19250104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of cardiac resynchronization guided by Doppler echocardiography: haemodynamic improvement and intraindividual variability with different pacing configurations and atrioventricular delays.
    Stockburger M; Fateh-Moghadam S; Nitardy A; Langreck H; Haverkamp W; Dietz R
    Europace; 2006 Oct; 8(10):881-6. PubMed ID: 16887867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal sensed atrio-ventricular interval determined by paced QRS morphology.
    Van Gelder BM; Bracke FA; Van Der Voort PH; Meijer A
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):476-81. PubMed ID: 17437570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison between IEGM-based approach and echocardiography in AV/PV and VV delay optimization in CRT-D recipients (Quicksept study).
    Giammaria M; Quirino G; Cecchi E; Senatore G; Pistelli P; Bocchiardo M; Mureddu R; Diotallevi P; Occhetta E; Magnani A; Bensoni M; Checchinato C; Conti V; Badolati S; Mazza A;
    Indian Pacing Electrophysiol J; 2016; 16(2):59-65. PubMed ID: 27676162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial.
    Krum H; Lemke B; Birnie D; Lee KL; Aonuma K; Starling RC; Gasparini M; Gorcsan J; Rogers T; Sambelashvili A; Kalmes A; Martin D
    Am Heart J; 2012 May; 163(5):747-752.e1. PubMed ID: 22607850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of impedance cardiography for optimizing the interventricular stimulation interval in cardiac resynchronization therapy-a comparison with left ventricular contractility.
    Sciaraffia E; Malmborg H; Lönnerholm S; Blomström P; Blomström Lundqvist C
    J Interv Card Electrophysiol; 2009 Sep; 25(3):223-8. PubMed ID: 19263200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimization of cardiac resynchronization therapy: importance of programmed parameters.
    Cuoco FA; Gold MR
    J Cardiovasc Electrophysiol; 2012 Jan; 23(1):110-8. PubMed ID: 22188487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fusion-optimized intervals (FOI): a new method to achieve the narrowest QRS for optimization of the AV and VV intervals in patients undergoing cardiac resynchronization therapy.
    Arbelo E; Tolosana JM; Trucco E; Penela D; Borràs R; Doltra A; Andreu D; Aceña M; Berruezo A; Sitges M; Mansour F; Castel A; Matas M; Brugada J; Mont L
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):283-92. PubMed ID: 24237881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of atrioventricular and ventriculoventricular delay optimization on clinical and echocardiographic outcomes of patients treated with cardiac resynchronization therapy: a meta-analysis.
    Auger D; Hoke U; Bax JJ; Boersma E; Delgado V
    Am Heart J; 2013 Jul; 166(1):20-9. PubMed ID: 23816017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac resynchronization therapy in patients with ischemic versus non-ischemic heart failure: Differential effect of optimizing interventricular pacing interval.
    Marsan NA; Bleeker GB; Van Bommel RJ; Borleffs C; Bertini M; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Am Heart J; 2009 Nov; 158(5):769-76. PubMed ID: 19853696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Programmed versus effective VV delay during CRT optimization: when what you see is not what you get.
    Bogaard MD; Meine M; Doevendans PA
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):403-9. PubMed ID: 23305237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shorter AV delays provide improved echocardiographic hemodynamics during exercise in patients receiving cardiac resynchronization therapy.
    Grimm RA; Sun JP; Agler D; Fitzgerald B; Wilkoff B; Hilpisch K; Perlic G; Chinchoy E
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):457-65. PubMed ID: 19335854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Automatic optimization of cardiac resynchronization therapy using SonR-rationale and design of the clinical trial of the SonRtip lead and automatic AV-VV optimization algorithm in the paradym RF SonR CRT-D (RESPOND CRT) trial.
    Brugada J; Brachmann J; Delnoy PP; Padeletti L; Reynolds D; Ritter P; Borri-Brunetto A; Singh JP
    Am Heart J; 2014 Apr; 167(4):429-36. PubMed ID: 24655689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy.
    Gold MR; Niazi I; Giudici M; Leman RB; Sturdivant JL; Kim MH; Yu Y; Ding J; Waggoner AD
    J Cardiovasc Electrophysiol; 2007 May; 18(5):490-6. PubMed ID: 17313533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Right ventricular contractility as a measure of optimal interventricular pacing setting in cardiac resynchronization therapy.
    Sciaraffia E; Malmborg H; Lönnerholm S; Blomström P; Blomström Lundqvist C
    Europace; 2009 Nov; 11(11):1496-500. PubMed ID: 19812048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.
    Whinnett ZI; Sohaib SM; Jones S; Kyriacou A; March K; Coady E; Mayet J; Hughes AD; Frenneaux M; Francis DP;
    BMC Cardiovasc Disord; 2014 Apr; 14():42. PubMed ID: 24693953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Why, how and when do we need to optimize the setting of cardiac resynchronization therapy?
    Bertini M; Delgado V; Bax JJ; Van de Veire NR
    Europace; 2009 Nov; 11 Suppl 5():v46-57. PubMed ID: 19861391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.